Close Menu

CHICAGO – Roche is terminating its precision medicine partnership with software developer Syapse later this month, the pharmaceutical and diagnostics giant confirmed Friday. The deal will end Dec. 18, less than two years after it began, a company spokesperson said.

"As partnerships evolve, priorities and timelines can change, resulting in a reassessment of where to focus resources," Roche spokesperson Patrick Barth told GenomeWeb via email. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.